7 suppressor strain with a mutation in gdpP, which showed the expected increase in c-di-AMP 150 levels, the 7 suppressor strains chosen for further analysis did not show an increase in the 151 cellular c-di-AMP concentration ( Fig. 1B ). Of note, as the relative c-di-AMP levels were 152 assessed using a competitive ELISA assay, a decrease in the A490 reading corresponds to an 153 increase in c-di-AMP level (Fig. 1B) . Next, genomic variations in the seven suppressor strains 154 compared to the original ltaS mutant strains were identified by whole genome sequencing. 155
Mutations were found in sgtB (SAUSA300_1855), coding for the monofunctional 156 glycosyltransferase SgtB and mutations in this gene arose independently in three suppressor 157 strains (Table 1) . Another strain had a mutation in SAUSA300_1254, coding for a hypothetical 158 membrane protein as well as SAUSA300_RS11150, encoding MazE, the antitoxin component 159 of a type II toxin-antitoxin module (Table 1 ). In the original study by Corrigan et al. (24) , 160 mutations found in SAUSA300_1254 were proposed to be accessory and required to further 161 improve the growth of the gdpP mutant suppressor strains. Consistent with a previous report 162
(2), a large deletion in clpX (SAUSA300_1621), encoding a protein forming part of an ATP-163 dependent protease, was observed in one strain (Table 1) . Finally, a mutation in vraT 164 (SAUSA300_1867), coding for the membrane protein VraT and forming part of the VraRST 165 three-component system, was identified. For one suppressor strain no single nucleotide 166 polymorphism was identified with a high confidence score, probably due to limited sequence 167 coverage. The mutations identified through the whole genome sequencing approach were 168 subsequently confirmed by fluorescent automated resequencing of the respective genomic 169 region. Some of the mutations observed in sgtB, as well as the mutations in vraT, clpX and 170 mazE result in frameshift mutations and introduction of premature stop codons, suggesting that Phenotypic characterization of the LTA negative S. aureus suppressor strains. In a 174 previous study, it was shown that S. aureus cells can grow without LTA in the absence of ClpX 175
(2), hence we did not further characterize the clpX mutant suppressor strain obtained as part of 176 this study. Instead our further analysis focused on suppressor strains with mutations in novel 177 genes, which are strains with mutations in mazE, sgtB or vraT. MazE, the antitoxin component 178 of a type II TA module, is part of the sigB regulon and has been shown to be essential for full 179 activity of the alternative sigma factor SigB (27). SigB and members of its regulon enable 180 bacteria to respond rapidly to environmental and antibiotic stresses and also play a role in cell 181 envelope homeostasis (28, 29) . Various studies have investigated the role of the VraTSR three-182 component regulatory system and this system has been reported to be involved in the induction 183 of the cell wall stressosome, mainly in the presence of cell wall targeting antibiotics (30) (31) (32) . 184
Interestingly, the monofunctional glycosyltransferase SgtB, also identified as part of our 185 screen, is one of the proteins belonging to the cell wall stressosome whose expression is 186 regulated by VraTSR independent of the presence of cell wall targeting antibiotics (30). To 187 further characterize the suppressor strains, we first confirmed the growth improvement of 188 strains S2-mazE, S4-sgtB and S7-vraT when propagated in TSB. All three suppressor strains 189 grew significantly better compared to the original ltaS mutant strain and their growth rate was 190 only slightly reduced compared to the WT LAC* stain ( Fig. 2A) . Next, the cell morphology of 191 the WT, original ltaS mutant and the three suppressor strains was assessed by microscopy 192 following staining of the peptidoglycan with fluorescently labelled vancomycin. The cell 193 morphology of the suppressor strains was considerably improved and in particular for 194 suppressor strain S2-mazE the division site was correctly placed in most cells ( Fig. 2B ). Next, 195 the susceptibility of the suppressor strains to a number of cell wall targeting antibiotics was 196 determined. Although the growth and cell morphology of the suppressor strains were improved, 9 susceptibility to the cell wall or membrane targeting antibiotics lysostaphin, nisin, vancomycin 199 or daptomycin was slightly reduced in the suppressor strains with the exception of suppressor 200 strain S2-mazE, which showed a slight increase in resistance to lysostaphin and daptomycin 201 (Table 2) . Finally, the growth of the three different suppressor strains was assessed on plates 202 containing Congo red. Congo red is an anionic azo dye traditionally used for the detection of 203 biofilms in Staphylococcus. However, at higher concentrations it inhibits the growth of S. 204 aureus and has been used in the past to indicate differences in the cell wall integrity of different 205 S. aureus strains (33). Recently, the target of Congo red has been established as the LTA 206 synthase enzyme LtaS (34). Hence our suppressor strains, which are deleted for ltaS and are 207 able to grow in the absence of LTA, should be resistant to this dye. To test the susceptibility of 208 the suppressor strains, serial dilutions of overnight cultures were spotted on TSA plates 209 containing 0.1% Congo red (Fig. 2C ). The suppressor strains carrying mutations in mazE and 210 sgtB were significantly more resistant to Congo red than the WT strain, indicating that 211 inactivation of either one of these genes is indeed sufficient to bypass the LTA essentiality. 212 However, the suppressor strain with the mutation in vraT grew poorly on the Congo red plates, 213 suggesting that this strain might not be a bona-fide suppressor strain and hence this strain was 214 not further investigated. 215 216 Introduction of SgtB or MazE in the respective suppressor strain results in the expected 217 growth arrest. The result of the whole genome sequencing analysis suggested that inactivation 218 of MazE or SgtB is sufficient to allow S. aureus to grow in the absence of LTA. Introduction 219 of a wild-type copy of mazE or sgtB into the respective suppressor strain should revert this 220 phenotype and be lethal for the suppressor strains when grown in un-supplemented medium 221 but should not have an effect when the bacteria are propagated in medium supplemented with 222 40% sucrose. In order to test this, plasmids piTET-mazE or piTET-sgtB, allowing for 223 anhydrotetracycline (Atet) inducible gene expression, were introduced into the respective 224 suppressor strains. As control, these plasmids were also introduced in the WT LAC* strain. 225
Serial dilutions of these different strains were spotted onto TSA plates containing 100 ng/ml 226 or 200 ng/ml Atet for the expression of mazE or sgtB expression, respectively. As expected for 227 a successful complementation, the expression of mazE prevented the growth of the suppressor 228 strain S2-mazE ( Fig. 3A ) and the expression of sgtB prevented the growth of the suppressor 229 strain S4-sgtB ( Fig. 3B ) on TSA but had no effect when the bacteria were spotted on medium 230 supplemented with 40% sucrose (Fig. 4 ). The result of this complementation analysis supports 231 the notion that inactivation of SgtB or MazE is sufficient to allow S. aureus to grow in the 232 absence of LTA. 233 234 Growth characterization and antibiotic resistance of an S. aureus LAC* sgtB mutant. 235 Inactivation of MazE likely has pleotropic effects due to its involvement in the activity of the 236 alternative sigma factor SigB and the reason as to why its inactivation allows S. aureus to grow 237 in the absence of LTA could be indirect. Hence, we next focused in trying to gain a better 238 understand of the cellular function of the monofunctional peptidoglycan glycosyltransferase 239 SgtB and how its inactivation allows S. aureus to survive in the absence of LTA. To this end, 240 the sgtB mutant strain LAC*sgtB::tn was constructed by moving the genomic region with a 241 transposon insertion in sgtB from the Nebraska transposon mutant library strain NE596 (35) 242 into the LAC* background. SgtB is one of two monofunctional peptidoglycan 243 glycosyltransferases encoded in the S. aureus genome and the protein can polymerize 244 peptidoglycan glycan chains in vitro (36). Although it is dispensable for the growth of S. 245 aureus, SgtB becomes necessary for bacterial survival in the absence of the main 246 glycosyltransferase PBP2 (10, 11, 37). Consistent with these previous observations, no 247 difference was observed in the cell growth and morphology of the sgtB mutant S. aureus strain 248 LAC*sgtB::tn as compared to the WT LAC* strain ( Fig. 5A and 5B ). Our results indicate that 249 inactivation of SgtB allows S. aureus to survive in the absence of LTA, therefore the sgtB 250 mutant strain should no longer be sensitive to the Congo red dye. To test this, serial dilutions 251 of the WT, the sgtB mutant and a complementation strain were spotted on TSA plates 252 containing 0.1% Congo red, which inhibits the LtaS enzyme. Indeed, the sgtB mutant strain 253 was considerably more resistant to Congo red than the WT strain and this phenotype could be 254 complemented by introducing a functional copy of sgtB into the mutant strain ( Fig. 5C ). 255
Moreover, the sgtB mutant strain showed increased resistance to the cell wall or membrane 256 targeting antibiotics oxacillin, lysostaphin, nisin and daptomycin as compared to the WT strain 257 and this phenotype could be complemented by introducing a functional copy of sgtB (Table 2) . 258
Taken together, while no growth or drastic morphological differences were observed between 259 the WT and the sgtB mutant strain, deletion of sgtB leads to increased Congo red dye and 260 antibiotic resistance in our strain background. 261 262 Inactivation of SgtB leads to an increase in peptidoglycan cross-linking in an LTA-263 negative S. aureus strain. Since SgtB is involved in peptidoglycan synthesis and the sgtB 264 mutant displayed increased antibiotic resistance, we hypothesised that its deletion could 265 somehow "strengthen" the cell wall through alterations in the peptidoglycan structure. In order 266 to investigate this, the muropeptide profiles of peptidoglycan isolated from the WT LAC*, the 267 sgtB mutant strain LAC*sgtB::tn, and the ltaS/sgtB mutant suppressor strain S4-sgtB was 268 determined following the growth of these strains in TSB. In addition, the muropeptide profile 269 was also determined for peptidoglycan isolated from these three strains as well as the original 270 ltaS mutant strain following growth in TSB supplemented with 40% sucrose (Fig. 6 ). The WT fragments showed that the peptidoglycan is highly crosslinked in both strains with 274 approximately 70% of the UV absorbing material found in the higher oligomeric fraction (Fig. 275 6B and 6C). No drastic difference was found in the muropeptide profile between the WT and 276 sgtB mutant strain and growth of these strains in TSB supplemented with 40% did also not 277 drastically alter the muropeptide profile as compared to the profile from the TSB grown strains 278 ( Fig. 6) . In contrast to the WT and sgtB mutant strain, a smaller amount of higher-oligomeric 279 peptidoglycan material was observed for the ltaS suppressor strain S4-sgtB both in TSB and 280 TSB sucrose medium (Fig 6. ). But perhaps most notably, a comparison of the muropeptide 281 profile of peptidoglycan isolated from the original ltaS mutant and the ltaS/sgtB suppressor 282 strain S4-sgtB after growth in TSB sucrose medium showed that, while the amount of 283 crosslinked peptidoglycan was reduced in both strains compared to the WT, the peptidoglycan 284 in the suppressor strain was more crosslinked as compared to the original ltaS mutant strain 285 ( Fig 6B and 6C) . Taken together, these data highlight that deletion of ltaS leads to a drastic 286 reduction in the amount of crosslinked peptidoglycan in S. aureus. Inactivation of SgtB in a 287 WT strain does not drastically affect the amount of crosslinked peptidoglycan, as one might 288 have expected based on the observed increase in resistance to cell wall active antibiotics. 289
However, in an LTA negative background strain, inactivation of SgtB leads to an increase in 290 peptidoglycan crosslinking, which might explain why an LTA negative strain can growth in 291 the absence of this monofunctional peptidoglycan glycosyltransferase. 292 293
Discussion 294
The anionic LTA polymer is a core component of the cell wall, essential for survival and a 295 number of studies have shown its importance in various cell processes (see review (38)). 296
Phenotypes caused by the depletion of LTA in S. aureus are misplacement and incomplete 297 formation of cell division septa, enlargement of the cells, together ultimately leading to cell 298 lysis (18, 24). However, how LTA mediates these roles is still unknown. In previous work, it 299 has been shown that LtaS and other core LTA synthesis proteins physically interact with early 300 and late stage cell division proteins as well as with a number of peptidoglycan synthesis 301 proteins (39) . This indicates that LTA synthesis enzymes might at least transiently be part of 302 multi-enzyme complexes which might help to coordinate LTA synthesis with peptidoglycan 303 synthesis and cell division (39) . We have previously shown that S. aureus mutants producing 304 increased intracellular c-di-AMP levels can survive without LTA (24). It is now believed that 305 at high c-di-AMP levels and through the c-di-AMP-dependent regulation of potassium and 306 osmolyte transporters, the internal turgor pressure in the cell might be reduced so that the 307 compromised LTA-depleted cell wall can sustain the the internal pressure (24, 40-42). Indeed, 308
as part of the current study we show that the absence of LTA leads to a drastic reduction in the 309 amount of cross-linked peptidoglycan in S. aureus (Fig. 6 ). This is consistent with the idea that 310 in the absence of LTA the cell wall is likely less able to sustain the high internal turgor pressure, 311 which might also contribute to the increased β-lactam sensitivity of LTA-negative strains 312 observed in this and previous studies (Table 2) (2, 24). The reason for the reduced amount of 313 peptidoglycan crosslinking is currently not clear but could potentially be due to mislocalization 314 of PBPs in the absence of LTA or PBPs having reduced enzyme activity since the proper ion 315 homeostasis cannot be maintained within the cell wall in the absence of LTA. 316
The aim of this study was to further elucidate the role of LTA in cell wall assembly and 317 potentially uncover additional proteins involved in the maintenance of cell wall integrity. A 318 suppressor screen followed by whole genome sequencing revealed mutations in genes coding 319 for ClpX, SgtB, MazE and VraT (Table 1 ) that can bypass the essentiality of LTA. Further 320 experimentation indicated that the strain with the mutation in vraT might not be a bona fide 321 suppressor strain. On the other hand, complementation analysis and growth assays on agar 322 plates containing the azo dye Congo red that prevents the growth of S. aureus by inhibiting the 323 LtaS enzyme (34) confirmed that inactivating mutations in sgtB and mazE could bypass the 324 essentiality of LTA. In a previous study it was found that an S. aureus clpX mutant readily 325 acquires inactivating mutations in ltaS resulting in the generation of LTA negative strains (2). 326
Conversely and consistent with this previous work, in this study we found in one of our LTA-327 negative suppressor strains a large deletion in clpX (Table 1) . ClpX is a protein folding 328 chaperon, which recognizes and targets proteins for degradation to the ClpP protease 329 component. In the absence of ClpX, S. aureus cells become smaller, show increased production 330 of autolysins and bacteria have a severe growth defect at temperatures of 30˚C or lower (2). 331
The introduction of loss of function mutations in the gene coding for the LTA synthase LtaS 332 in a clpX mutant alleviates some of these effects. This is perhaps due to LTA depletion having 333 an opposite effect that is leading to an increase in cell size and decreased in autolysis as reported 334 in some previous publications (2, 20) . 335
Mutations in the monofunctional glycosyltransferase SgtB were the most prevalent 336 mutations that arose in our suppressor screen. Previous studies have shown that SgtB is not 337 essential for the survival of the cell and as reported in this and a previous study, an sgtB mutant 338 strain does not show any obvious growth or morphological differences as compared to a WT 339 strain under standard growth conditions ( Fig. 5 ) (11). Interestingly, we found that the sgtB 340 mutant strain LAC*sgtB::tn was 2-fold more resistant to a number of cell-targeting antibiotics 341 and this phenotype could be complemented by introduction of a wild-type copy of sgtB (Table  342 2). These results are in accordance with previous reports, where strains with mutations in genes 343 that compensate for the lack of LTA, such as gdpP and clpX mutant strains, also show increased 344 oxacillin resistance (2, 24). 345
The increased resistance to cell wall-targeting antibiotics of the sgtB mutant prompted 346 us to investigate the peptidoglycan structure of an sgtB mutant in more detail, as we 347 hypothesized that in its absence changes such as an increased crosslinking might be observed that could potentially explain the increased resistance. However, we could not detect any 349 drastic changes in the muropeptide profile of an sgtB mutant strain as compared to a WT strain 350 ( Fig. 6 ). On the other hand, the original ltaS mutant strain showed a drastic reduction of around 351 30% in the higher oligomeric crosslinked peptidoglycan (Fig. 6 ). But perhaps most 352 importantly, the peptidoglycan isolated from the sgtB/ltaS double mutant S4-sgtB suppressor 353 strain showed an increase in peptidoglycan crosslinking as compared to the original ltaS mutant 354 strain ( Fig. 6 ). We speculate that this increase in peptidoglycan cross-linking could potentially 355 strengthen the cell wall to better sustain the high internal turgor pressure and be at least in part 356 responsible for the observed growth improvement. Bacterial two-hybrid studies have indicated 357 that the S. aureus SgtB protein interacts with SgtA, PBP1, PBP2 and PBP2A (11). Therefore, has been shown to be required for full activity of the alternative sigma factor SigB (27). It has 369 also been reported that overexpression of σ B causes cell wall thickening in S. aureus and 370 increased resistance to cell wall-targeting antibiotics (28). Therefore, inactivation of MazE, as 371 observed in one of our suppressor strains, could potentially also affect cell wall homeostasis 372 via its effect on SigB. 373
In summary, our results suggest that in the absence of LTA, peptidoglycan in S. aureus 374 becomes less cross-linked, which might weaken the cell wall and become less able to sustain 375 the high internal turgor pressure, ultimately leading to cell lysis. The suppressor mutations 376 obtained in sgtB (and perhaps also in some of the other genes observed in our screen) help the 377 cell survive this detrimental effect by altering and strengthening the cell wall, likely allowing 378 the cell wall to again better withstand the high internal turgor pressure. 379 380
Materials and Methods 381
Bacterial strains and culture conditions. All bacterial strains used in this study are listed in 382 Table 3 . Escherichia coli strains were cultured in Luria Bertani (LB) medium and 383
Staphylococcus aureus strains in tryptic soya broth (TSB) at 37°C with aeration, unless 384 otherwise stated. When appropriate the growth medium was supplemented with antibiotics and 385 inducers as follow: for E. coli cultures: ampicillin (Amp) 100 µg/ml, chloramphenicol (Cam) 386 10 µg/ml, and kanamycin (Kan) 30 µg/ml; for S. aureus cultures: chloramphenicol (Cam) 10 387 and plasmid piTET were digested with AvrII and SacII, ligated and then transformed into E. 399 coli XL1-Blue yielding strain XL1-Blue piTET-sgtB (ANG3926) and XL1-Blue piTET-mazE 400 (ANG4727). The plasmids were shuttled through E. coli strain IM08B (ANG3927 and 401 ANG4728) and subsequently electroporated into LAC* yielding strains LAC* piTET-sgtB 402 (ANG4056) and LAC* piTET-mazE (ANG4729) or into the respective suppressor strains 403 yielding strains S4-sgtB piTET-sgtB (ANG4058) and S2-mazE piTET-mazE (ANG4730). The 404 plasmid pCL55-sgtB for complementation and expression of sgtB from its native promoter was 405 generated by amplifying the sgtB gene including its native promoter region from LAC* 406 chromosomal DNA using primers ANG2270 and ANG2271. The PCR product and plasmid 407 pCL55 were digested with EcoRI and BamHI, ligated and then transformed into E. coli XL1-408
Blue yielding strain XL1-Blue pCL55-sgtB (ANG4708), shuttled through IM08B (ANG3923) 409 and subsequently electroporated into the sgtB mutant strain yielding strain LAC*sgtB::tn 410 pCL55-sgtB (ANG4711). WT LAC* or mutant S. aureus strains with the empty vectors piTET 411 or pCL55 (see Table 3 to an OD600 of 0.05 in Müller Hinton broth and 100 µl of these suspensions were incubated in 439 96-well plates with 2-fold dilutions of various antimicrobials at the following starting 440 concentrations: oxacillin 1.024 mg/ml or 1 µg/ml as appropriate, daptomycin 32 µg/ml, 441 lysostaphin 16 µg/ml, vancomycin 32 µg/ml, nisin 50 µg/ml and penicillin G 51.2 µg/ml or 0.2 442 µg/ml as appropriate. Oxacillin and daptomycin containing wells were supplemented with 2% 443 (w/v) NaCl and 0.23 mM CaCl2, respectively. Plates were incubated at 37°C for 15 hours with 444 shaking. MICs were determined as the concentration of antibiotic at which growth was 445 inhibited by >75% compared to growth without the antibiotic. 446 LTA detection by western blot. LTA extraction and detection by western blot was performed 448 as previously described (44). Briefly, samples were prepared from 1 ml overnight cultures 449 normalized based on OD600 readings, that is cells from 1 ml culture with an OD600 of 6 were 450 suspended in 90 µl 2 × SDS protein sample buffer. 10 µl of these samples were separated on 451 15% SDS-polyacrylamide gels and the material subsequently transferred to PVDF membranes. The next day, cells were back-diluted in 2 litres of the same growth medium to an OD600 of 481 0.05. The cultures were grown at 37°C until mid an OD600 of approximately 1.5, cooled on ice 482 and cells were collected by centrifugation. Peptidoglycan was purified and digested with 483 mutanolysin as previously described (24, 45) . HPLC analysis of the digested peptidoglycan 484 material was performed as described previously described (45) and the muropeptide profiles 485 were determined for each strain and growth condition in triplicates. For the quantification of 486 monomeric, dimeric, trimeric and higher oligomeric peptidoglycan material, the peaks were 487 integrated. The total peak area for each muropetide profile was determined and set to 100% 488 and the % monomeric, dimeric, trimeric, and higher oligomeric peaks calculated and the 489 average values and standard deviation from the three profiles determined and plotted. 490 491 c-di-AMP quantification by competitive ELISA. Five ml TSB were inoculated with a single 492 colony of S. aureus LAC* (WT), strain LAC* gdpP::kan, US3 (LAC*∆ltaSS::erm suppressor 493 with mutation in gdpP) as well as the different LTA-negative suppressor and the tubes were 494 incubated for 8 hours at 37°C. Next, the cultures were back-diluted to an OD600 of 0.05 in 10 495 ml TSB and grown for 15 hours at 37°C. Bacterial cells from these cultures were collected by previously described competitive ELISA method (25, 26). However, in place of determining 498 c-di-AMP levels based on a standard curve the A490 values were directly compared. To this 499 end, the A490 reading obtained for samples derived for the WT strain was set to 100% and the 500 % values calculated for the samples derived from the other strains. Thee independent 501 experiments were performed with three technical replicates and the average values and 502 standard deviation of the % A490 values determined for each strain as compared to the WT 503 strain. Of note, since this is a competitive ELISA, and a decrease in A490 readings represents 504 an increase in cellular c-di-AMP levels. Ser39fs 1 Suppressors S1, S2, S7 and S8 were derived from strain LAC*∆ltaSS (ANG2135) and 515 suppressor strains S3, S4 and S6 were derived from strain LAC*∆ltaSN (ANG2134). 516 2 Reference position indicates base number in the LAC* reference genome, which was 517 assembled as previously described (25). 3 The MIC was defined as antibiotic concentration that leads to > 75% growth inhibition as 528 compared to growth without antibiotic. 529 530 an ltaS mutant (strain ANG2135) and the 7 ltaS suppressor strains (S1-S4 and S6-S8) and 544 separated on a 15% PAA gel. LTA was subsequently detected by western blot using a 545 monoclonal polyglycerolphosphate specific antibody. A representative result from 3 546 independent experiments is shown. (B) c-di-AMP detection by competitive ELISA. 547
Cytoplasmic extracts were prepared from LAC* (WT), the high c-di-AMP level control strains 548 LAC* gdpP::kan (gdpP) and US3 (ltaS/gdpP) as well as from the 7 ltaS suppressor strains 549 (S1-S4 and S6-S8). c-di-AMP amounts were determined and compared to the WT strain by 550 ELISA. Of note, as this is a competitive ELISA assay, lower A490 readings are obtained for 551 samples with higher c-di-AMP levles. The A490 reading obtained for the sample derived from 552 the WT strain was set to 100% and % A490 reading calculated for the test strains. of mutanolysin digested peptidoglycan. Peptidoglycan was isolated and digested with 615 mutanolysin as described in the materials and methods section from S. aureus strains LAC* 616 (WT), LAC*sgtB::tn (sgtB) and the LTA negative suppressor strain S4-sgtB following growth 617 in TSB medium or from S. aureus strains LAC* (WT), LAC*sgtB::tn (sgtB), the LTA negative 618 suppressor strain S4-sgtB as well as the original ltaS mutant strain (ANG2135) following 619 growth in TSB 40% sucrose medium. Monomeric, dimeric, trimeric and > trimeric 620 peptidoglycan fragments are indicated above the graphs and a representative profile from three 621 independent samples is shown. (B-C) Quantification of the different peptidoglycan peaks. The 622 peaks corresponding to monomeric, dimeric, trimeric and > trimeric peptidoglycan fragments 623 were integrated and quantified for the strains used in panel A. The combined peak area was set 624 to 100% for each strain and the average values and standard deviations from the three 625 independent peptidoglycan isolations were plotted in panel B, for the strains grown in TSB 626 sucrose medium and in panel C for the strains grown in TSB medium. Statistical analysis to 627 identify differences in monomer, dimer, trimer or > trimer fractions between WT and mutant 628 strains was performed in Prism (GraphPad) using a Kruskal-Wallis test followed by a Dunn's 629 multiple comparison test. Adjusted p-values <0.1 are indicated by a single asterisk (*), adjusted 630 p-values < 0.05 by a double asterisk (**) and adjusted p-values < 0.01 by a triple asterisk (***). 631 632 633
